Concordia Pharms Inc Drug Patent Portfolio
Concordia Pharms Inc owns 3 orange book drugs protected by 4 US patents Given below is the list of Concordia Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6740341 | Taste masking rapid release coating system | 24 Nov, 2019 | Expired |
| US6024981 | Rapidly dissolving robust dosage form | 09 Apr, 2018 | Expired |
| US6221392 | Rapidly dissolving robust dosage form | 09 Apr, 2018 | Expired |
| US5869100 | Extended release clonidine formulation (tablet) | 13 Oct, 2013 | Expired |
Concordia Pharms Inc's Family Patents
Concordia Pharms Inc Drug List
Given below is the complete list of Concordia Pharms Inc's drugs and the patents protecting them.
1. Jenloga
Jenloga is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5869100 | Extended release clonidine formulation (tablet) |
13 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jenloga's drug page
2. Kapvay
Kapvay is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5869100 | Extended release clonidine formulation (tablet) |
13 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kapvay's drug page
3. Orapred Odt
Orapred Odt is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6740341 | Taste masking rapid release coating system |
24 Nov, 2019
(4 years ago)
| Expired |
| US6024981 | Rapidly dissolving robust dosage form |
09 Apr, 2018
(6 years ago)
| Expired |
| US6221392 | Rapidly dissolving robust dosage form |
09 Apr, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Orapred Odt's drug page